<code id='FDDBCF84E3'></code><style id='FDDBCF84E3'></style>
      • <acronym id='FDDBCF84E3'></acronym>
      <center id='FDDBCF84E3'><center id='FDDBCF84E3'><tfoot id='FDDBCF84E3'></tfoot></center><abbr id='FDDBCF84E3'><dir id='FDDBCF84E3'><tfoot id='FDDBCF84E3'></tfoot><noframes id='FDDBCF84E3'>
      • <optgroup id='FDDBCF84E3'><strike id='FDDBCF84E3'><sup id='FDDBCF84E3'></sup></strike><code id='FDDBCF84E3'></code></optgroup>
        5. <b id='FDDBCF84E3'><label id='FDDBCF84E3'><select id='FDDBCF84E3'><dt id='FDDBCF84E3'><span id='FDDBCF84E3'></span></dt></select></label></b><u id='FDDBCF84E3'></u>
          <i id='FDDBCF84E3'><strike id='FDDBCF84E3'><tt id='FDDBCF84E3'><pre id='FDDBCF84E3'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / entertainment / focus      
           
     
           
      
          focus 
           
      
           
      
           
       2025-09-28 05:38:57 
   
      
           
      
           
                        
          focus  
          
                                   
                 
                                      author：fashion   
                                        
                                      
                                      Page View：6163
                                  
                                    
          
                                   
          Editor’s note: A recording of the event is embedded below.
          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
          advertisement
          Featured Speakers
          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Vir antibody drug aimed at influenza A fails in clinical trial
                                
                            
          Next article：  
                                      
                                          New air purifier tech could be key to improving indoor air quality
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles